ARTICLE | Clinical News
Teflaro regulatory update
September 3, 2012 7:00 AM UTC
The European Commission approved an MAA from AstraZeneca for Zinforo ceftaroline to treat complicated skin and soft tissue infections (cSSTI) and community-acquired bacterial pneumonia (CABP). AstraZe...